Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism
- 1 September 1991
- Vol. 184 (1) , 187-196
- https://doi.org/10.1016/0042-6822(91)90835-y
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- C-Terminal Fragments of gpl20 and Synthetic Peptides from Five HTLV-III Strains: Prevalence of Antibodies to the HTLV-III-MN Isolate in Infected IndividualsAIDS Research and Human Retroviruses, 1990
- HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprisesImmunology Today, 1989
- Antibodies from Human Immunodeficiency Virus-Infected Individuals Bind to a Short Amino Acid Sequence that Elicits Neutralizing Antibodies in AnimalsAIDS Research and Human Retroviruses, 1989
- T-cell strategies in AIDS vaccinesAIDS, 1989
- Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptorCell, 1987
- pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneCell, 1987
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984